Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CK1delta

Home DrugsCK1delta

CK1delta

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES
US 2014031547 A1Applicant: SHERIDAN JOSEPH MPriority: 2010
US
3 publications
Protein Kinase Targeted Therapeutics
US 2008051410 A1Applicant: UNIV NORTHWESTERNPriority: 2007
US
2 publications
Application of WWC3 protein molecule to preparation of antitumor drug
CN 106492191 AApplicant: UNIV CHINA MEDICALPriority: 2016
CN
Medical application of CK1delta-USP46-NRAS mutant signaling pathway down-regulating agent and pharmaceutical composition of CK1delta-USP46-NRAS mutant signaling pathway down-regulating agent
CN 120771282 AApplicant: UNIV JINANPriority: 2024
CN